Fumagillin: Translational Leverage in Angiogenesis & Parasit
2026-04-28
This thought-leadership article examines Fumagillin’s mechanistic role as a methionine aminopeptidase-2 inhibitor in angiogenesis and tumor biology, extends its translational relevance to antiparasitic applications, and provides actionable guidance for researchers. Grounded in contemporary evidence and protocol best practices, it situates Fumagillin at the interface of oncology and aquatic disease management, differentiating the discussion from standard product overviews.
Efficient Synthesis of Deuterium-Labeled Degarelix Acetate:
2026-04-27
This study introduces a practical multistep method for synthesizing deuterium-labeled degarelix acetate, a crucial internal standard for pharmacokinetic and metabolism research. The work highlights the methodological advances, technical details, and analytical rigor enabling robust isotopic labeling of a clinically relevant GnRH receptor antagonist.
Deep Learning Identifies Cardiotoxicity in iPSC-CMs at Scale
2026-04-27
Grafton et al. introduce a scalable, high-content screening platform leveraging deep learning and human iPSC-derived cardiomyocytes to detect cardiotoxic compounds. This approach advances early drug safety evaluation, offering improved translational relevance and supporting more effective de-risking in pharmaceutical pipelines.
FLAG tag Peptide (DYKDDDDK): Technical Guide & Workflow QC
2026-04-26
The FLAG tag Peptide (DYKDDDDK) enables efficient detection and purification of recombinant proteins through its specific epitope sequence and compatibility with anti-FLAG affinity resins. It is best used in workflows requiring high solubility, gentle elution, and precise protein analysis. This peptide is not suited for eluting 3X FLAG fusion proteins or for workflows needing long-term peptide solution storage.
Promethazine HCl in Immunology: Protocols, Assays & Insights
2026-04-25
Promethazine HCl unlocks advanced immune and inflammation research by modulating histaminergic pathways and boosting macrophage antibacterial activity through ROS and autophagy induction. This article provides actionable workflows, protocol parameters, and troubleshooting strategies to maximize the translational impact of this phenothiazine derivative.
GSH and GSSG Assay Kit: Protocol Guidance and Troubleshootin
2026-04-24
The GSH and GSSG Assay Kit provides quantitative, spectrophotometric measurement of reduced and oxidized glutathione in biological samples. It is suitable for researchers studying oxidative stress and redox state but should not be used for unexplored matrices or mechanistic claims beyond glutathione quantification.
Thiamet G: Precision O-GlcNAcase Inhibitor for Disease Model
2026-04-24
Thiamet G, a potent and selective O-GlcNAcase inhibitor from APExBIO, empowers researchers to precisely modulate cellular O-GlcNAcylation for advanced studies in neurodegeneration and metabolic bone disorders. This guide details optimized workflows, troubleshooting strategies, and the integration of novel Wnt/O-GlcNAcylation findings to elevate experimental design.
Stattic: STAT3 Inhibitor Benchmarks for Cancer Biology
2026-04-23
Stattic is a selective STAT3 inhibitor that disrupts STAT3 signaling, showing potent activity in head and neck squamous cell carcinoma (HNSCC) models. Its mechanism involves blocking STAT3 dimerization, reducing tumor growth, and enhancing radiosensitivity. This article details evidence, parameters, and critical limitations for researchers.
USP42 Drives Breast Cancer Progression via JNK/p38 Apoptosis
2026-04-23
This study demonstrates that the deubiquitinating enzyme USP42 is upregulated in breast cancer and promotes tumor growth by inhibiting JNK/p38-mediated apoptosis. These findings highlight USP42 as a potential therapeutic target and inform molecular pathway research in oncology.
CK2 and ERK8 Inhibitor: Mechanism, Evidence, and Use Cases
2026-04-22
The CK2 and ERK8 inhibitor (2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid) is a potent small molecule inhibitor targeting key kinases in cell signaling. As a high-purity, DMSO-soluble biochemical reagent, it enables precise modulation of kinase-driven phosphorylation events in research settings. This article clarifies its mechanism, evidence base, and critical workflow parameters for advanced protein interaction studies.
Norepinephrine to Angiotensin II Dosing in Vasodilatory Shoc
2026-04-22
This article reviews a post-hoc analysis of the ARAMIS trial, which established a median norepinephrine to angiotensin II conversion ratio of 10:1 in vasodilatory hypotension patients. The findings clarify dosing strategies for angiotensin II in critical care and explore how prior angiotensin receptor blocker (ARB) exposure modifies these requirements.
Tandem ssDNA in NETs Binds Thrombin to Regulate Immunothromb
2026-04-21
This study reveals that specific tandem repeats of single-stranded DNA (ssDNA), namely (ATTCC)n motifs, within neutrophil extracellular traps (NETs) directly bind thrombin and enhance immunothrombosis. The findings provide new insights into DNA-mediated regulation of coagulation and suggest targeted disruption of these interactions as a potential therapeutic strategy.
Olsalazine Sodium: Advanced Insights for Tumor Apoptosis and
2026-04-21
Explore Olsalazine Sodium as a mesalamine dimer and anti-inflammatory prodrug with exceptional efficacy in colorectal cancer models. This article delivers novel protocol guidance and translational assay insights rarely addressed elsewhere.
Zosuquidar (LY335979) 3HCl: Precision P-gp Inhibition in Can
2026-04-20
Explore the advanced scientific rationale and assay optimization strategies for Zosuquidar (LY335979) 3HCl, a selective P-glycoprotein inhibitor. This article uniquely bridges pharmacokinetic insights with practical workflow guidance for multidrug resistance studies in cancer.
BGJ398 (NVP-BGJ398): Potent FGFR1/2/3 Inhibitor for Oncology
2026-04-20
BGJ398 (NVP-BGJ398) is a highly selective small-molecule FGFR1/2/3 inhibitor used in oncology research. Its nanomolar potency, specificity, and established benchmarks make it a cornerstone for investigating FGFR-driven malignancies and apoptosis induction in cancer cells.
479 records 22/32 page Previous Next First page 上5页 2122232425 下5页 Last page